Nociceptin, the endogenous
ligand of the inhibitory
G protein-coupled
opioid receptor-like 1 receptor, produces aquaresis (i.e., increases the excretion of solute-free urine) in rats. However, the mechanism underlying this effect has not yet been explained. Using immunohistochemistry, we found the
opioid receptor-like 1 receptor in the rat kidney colocalized with the
vasopressin-regulated
water channel aquaporin-2 in inner medullary collecting ducts. We investigated the aquaretic effect of
opioid receptor-like 1 receptor stimulation by infusing the selective
nociceptin analog ZP120C; volume depletion was prevented by computer-driven, servo-controlled intravenous volume replacement with 50 mM
glucose. ZP120C induced a marked and sustained aquaresis in normal and
congestive heart failure rats in the absence of changes in
vasopressin plasma concentrations. The ZP120C-induced aquaresis was associated with downregulation of the
aquaporin-2 protein level in both rat groups, suggesting that
opioid receptor-like 1 receptor stimulation produces aquaresis by inhibiting the
vasopressin type-2 receptor-mediated stimulation on collecting duct water reabsorption. However, substantial amounts of PKA-mediated
serine 256 phosphorylated
aquaporin-2 were still present after 4 h of ZP120C treatment. Furthermore, neither preincubation with
nociceptin nor ZP120C inhibited
vasopressin-mediated cAMP accumulation in isolated collecting ducts. We conclude that renal
opioid receptor-like 1 receptor stimulation in normal and
congestive heart failure rats produces aquaresis by a direct renal effect, via
aquaporin-2 downregulation, through a mechanism not involving inhibition of
vasopressin type-2 receptor-mediated cAMP production.